Research Group in Immunology and Metabolism (GRIM)

Publications (363)

Publication Search

Castelblanco, E.; Hernandez, M.; Castelblanco, A.; Esquerda, A.; Mollo, A.; Ramirez-Morros, A.; Franch-Nadal, J.; Fernandez-Real, J. M.; Mauricio, D.

Low-grade inflammatory marker profile is mainly driven by adiposity-related characteristics in patients with LADA, type 1 and type 2 diabetes

DIABETOLOGIA 60 200-200. .

Lecube, A.; Sanchez, E.; Betriu, A.; Gutierrez-Carrasquilla, L.; Elias, M.; Barbe, F.; Purroy, F.; Buti, M.; Fernandez, E.; Lopez-Cano, C.

Impaired pulmonary function in type 2 diabetes: Is there a role for advanced glycation end-products measured by skin autofluorescence?Data form the ILERVAS project

DIABETOLOGIA 60 503-503. .

Eritja, N; Felip, I; Dosil, MA; Vigezzi, L; Mirantes, C; Yeramian, A; Navaridas, R; Santacana, M; Llobet-Navas, D; Yoshimura, A; Nomura, M; Encinas, M; Matias-Guiu, X; Dolcet, X

A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-beta in mouse endometrium

CELL DEATH AND DIFFERENTIATION 24 1443-1458. .

[doi:10.1038/cdd.2017.73]

Hernandez, M; Lopez, C; Real, J; Valls, J; Ortega-Martinez de Victoria E; Vazquez, F; Rubinat, E; Granado-Casas, M; Alonso, N; Moli, T; Betriu, A; Lecube, A; Fernandez, E; Leslie, RD; Mauricio, D

Preclinical carotid atherosclerosis in patients with latent autoimmune diabetes in adults (LADA), type 2 diabetes and classical type 1 diabetes

Cardiovascular Diabetology 16 94-94. .

[doi:10.1186/s12933-017-0576-9]

Perez-Segura, P; Palacio, JE; Vazquez, L; Monereo, S; de Las Peñas R; de Icaya, PM; Gravalos, C; Lecube, A; Blasco, A; Garcia-Almeida, JM; Barneto, I; Goday, A

Peculiarities of the obese patient with cancer: a national consensus statement by the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology

Clinical & Translational Oncology 19 682-694. .

[doi:10.1007/s12094-016-1601-2]

Mizab Mellah, Chadia; Sanchez Perez, Marta; Santos Rey, Maria Dolores; Hernandez Garcia, Marta

Fulminant type 1 diabetes mellitus associated with pembrolizumab

Endocrinologia Diabetes y Nutricion 64 272-273. .

[doi:10.1016/j.endinu.2017.01.005]

Ridker PM; Revkin J; Amarenco P; Brunell R; Curto M; Civeira F; Flather M; Glynn RJ; Gregoire J; Jukema JW; Karpov Y; Kastelein JJP; Koenig W; Lorenzatti A; Manga P; Masiukiewicz U; Miller M; Mosterd A; Murin J; Nicolau JC; Nissen S; Ponikowski P; Santos RD; Schwartz PF; Soran H; White H; Wright RS; Vrablik M; Yunis C; Shear CL; Tardif JC; SPIRE Cardiovascular Outcome Investigators

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients.

NEW ENGLAND JOURNAL OF MEDICINE 376 1527-1539. .

[doi:10.1056/NEJMoa1701488]

Vilarrasa, N; Rubio, M; Miñambres I; Flores, L; Caixàs A; Ciudin, A; Bueno, M; Garcia-Luna, P; Ballesteros-Pomar, M; Ruiz-Adana, M; Lecube, A

Long-Term Outcomes in Patients with Morbid Obesity and Type 1 Diabetes Undergoing Bariatric Surgery

OBESITY SURGERY 27 856-863. .

[doi:10.1007/s11695-016-2390-y]

Lecube, A; Sanchez, E; Lopez-Cano, C; Hernandez, C; Simo, R

Type 2 diabetes, risk of sleep apnea-hypopnea syndrome, and quality of life associated to sleep breathing disorders Diabetes

Endocrinologia Diabetes y Nutricion 64 174-176. .

[doi:10.1016/j.endinu.2016.10.009]

del Pino, AS; Medina-Rodriguez, N; Hernandez-Garcia, M; Novoa-Mogollon, FJ; Wagner, AM; Spanish Type 1 Diabet Genetics; T1DGC

Is HLA the cause of the high incidence of type 1 diabetes in the Canary Islands? Results from the Type 1 Diabetes Genetics Consortium (T1DGC)

Endocrinologia Diabetes y Nutricion 64 146-151. .

[doi:10.1016/j.endinu.2016.12.003]

Lecube, A; Monereo, S; Rubio, MA; Martinez-de-Icaya, P; Marti, A; Salvador, J; Masmiquel, L

Prevention, diagnosis, and treatment of obesity. 2016 position statement of the Spanish Society for the Study of Obesity

Endocrinologia Diabetes y Nutricion 64 15-22. .

[doi:10.1016/j.endien.2017.03.007]

Sanchez, E; Betriu À; Arroyo, D; Lopez, C; Hernandez, M; Rius, F; Fernandez, E; Lecube, A

Skin Autofluorescence and Subclinical Atherosclerosis in Mild to Moderate Chronic Kidney Disease: A Case-Control Study

PLoS One 12 -. .

[doi:10.1371/journal.pone.0170778]